What is Steel Partners' offer price for InMode?

Steel Partners has made an unsolicited all-cash acquisition proposal of $16.75 per share for InMode, directly competing against a CEO-led buyout bid. This represents a significant valuation challenge to the competing proposal and signals serious PE interest in the RF microneedling and energy-device platform.

What devices does InMode manufacture?

InMode's portfolio includes RF microneedling systems, fractional CO2 lasers, and monopolar RF devices. These systems have a meaningful installed base across independent medspas and dermatology practices, though the company faces competitive pressure from lower-cost RF alternatives.

Why is InMode facing margin pressure?

InMode is experiencing margin compression from hardware commoditization and increased competition from lower-cost RF alternatives entering the market. This competitive and pricing pressure is contributing to investor uncertainty around the company's growth trajectory.

What could happen to InMode's product line if Steel Partners acquires it?

A Steel Partners acquisition would likely trigger operational restructuring, including possible SKU rationalization and go-to-market consolidation. This suggests the acquirer may streamline InMode's product offerings and sales strategy post-acquisition.

Is Steel Partners already an InMode shareholder?

Yes, Steel Partners is an existing InMode shareholder making this an unsolicited bid. This insider position gives Steel Partners both knowledge of the business and leverage in the acquisition process.

Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →

RegulatoryAbbVie Launches Phase 2 Forehead Lines Studytoday MarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days ago Business & M&AAllergan Aesthetics Overhauls Loyalty Programtoday Devices & TechXERF Technology Enters Australian Market for Skin Tightening2 days ago Business & M&AEvolus Expands Estyme to Canada, Australia, New Zealandtoday MarketArm Fat Now Top Body Sculpting Concern in Singapore2 days ago Devices & TechSofwave Hits One Million Treatments Milestonetoday RegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days ago RegulatoryRevance Wins FDA Nod for Under-Eye Injectablesyesterday MarketGLP-1 Pill Era Is Forcing Beauty Market Shiftyesterday InjectablesAEON Releases Expanded ABP-450 Botox Biosimilar Datayesterday Devices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday

Business & M&A

Steel Partners Offers $16.75/Share for InMode — Rival Bid Challenges CEO Buyout

Unsolicited cash offer from major shareholder tops competing proposal; device maker's board faces competing valuations.

By Evan at Inside MedSpa · Jul 13, 2026

1-YEAR MOVE

INMD ▲1.0%

1-year price move by ticker
Ticker	Company	1-year change
INMD	InMode Ltd.	+1.0%

Steel Partners, an existing InMode shareholder, has tabled an unsolicited $16.75-per-share all-cash acquisition proposal, directly challenging a competing CEO-led buyout bid. The move signals serious PE interest in the RF microneedling and energy-device platform at a time when InMode's market valuation reflects investor uncertainty around growth trajectory and competitive positioning.

Inside MedSpa Pro

You've reached your free articles this week.

Keep reading every article, unlock the full trackers, and get the twice-a-week intelligence brief — from $20/mo, or $200/yr (two months free). Never miss a recall or a rule change.

Every article, unlocked — no weekly limit
The full 50-state law tracker, stock & M&A watch
The twice-a-week, 2-minute intelligence brief
Recalls, FDA clearances & safety signals as they hit

See everything you get →

Cancel anytime, one click · 14-day money-back on annual

https://insidemedspa.com/article/steel-partners-16-75-inmode-bid/

Discussion

Free alerts

Get flagged before it costs you.

We'll flag the moment a recall or rule change hits your practice. One email a week, one click to leave.

Free · weekly · unsubscribe anytime. Privacy.

This morning's brief · 6 AM

The free version stops here.

What today's moves mean for your margins — and exactly what to do — already went out to Pro. By the time the trade press explains it, the window to act has closed.

Go Pro · $20/mo Two minutes a morning. Cancel anytime.

Live · Market movers

STRATA Skin Sciences-50%Hims & Hers Health+6.03%Estée Lauder+6.02%Bausch Health (Solta)-5.43%The Beauty Health Company (HydraFacial)+3.65%

The full stock & M&A watch →

FDA Activity — Aesthetic Devices

Monthly 510(k) clearances vs. recalls.

510(k) clearances Recalls

FDA Activity — Aesthetic Devices — Monthly 510(k) clearances vs. recalls.
Month	510(k) clearances	Recalls
Jun '25	0	4
Jul '25	0	1
Sep '25	0	1
Oct '25	0	2
Jan '26	0	1
Feb '26	0	5
Mar '26	0	5
Apr '26	0	19
May '26	7	18
Jun '26	34	8
Jul '26	23	4
Aug '26	5	0

The 50-state regulation tracker →

Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.

The twice-a-week intelligence brief Go Pro · $20/mo →

Steel Partners Offers $16.75/Share for InMode — Rival Bid Challenges CEO Buyout

Share

Discussion

Leave a comment

By the time it's news, it's too late.